Listed on the Australian Stock Exchange, Optiscan (OIL) is an Australian company that has developed and patented miniaturised confocal microscopes, and is now a global leader in the development and application of microscopic imaging technologies for medical markets.
With the high cost of curative medicine an opportunity exists for Optiscan’s technology to be used globally to reduce costs and be used as a key tool for:
> early detection of disease
> use throughout stages when disease can be treated easily and effectively
> providing a means to monitor responses at the cellular level so as to enable improvement to treatment outcomes